Summary by Futu AI
CR Group L.P. has reported a series of acquisitions of common stock in T2 Biosystems, Inc. [TTOO], according to a filing dated 05/03/2024. The transactions were made indirectly through various entities associated with CR Group L.P. A total of 648,139 shares were acquired by CRG Partners III L.P., 403,608 shares by CRG Partners III - Parallel Fund (A) L.P., 129,629 shares by CRG Partners III (Cayman) Unlev AIV I L.P., 1,565,445 shares by CRG Partners III (Cayman) Lev AIV I L.P., and 2,001,514 shares by CRG Partners III - Parallel Fund B (Cayman) L.P. These acquisitions were classified under the transaction code 'A', indicating a grant, award, or other acquisition of securities. Following these transactions, the total number of shares held by CR Group L.P. in T2 Biosystems stands at 8,853,173. The nature of the indirect beneficial ownership is specified for each entity involved in the acquisitions.